Submission for OMB Review; 30-Day Comment Request: The National Physician Survey of Precision Medicine in Cancer Treatment (NCI), 9869-9870 [2016-04105]

Download as PDF 9869 Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices evidence that environmental chemicals, physical substances, or mixtures (collectively referred to as ‘‘substances’’) cause adverse health effects and provides opinions on whether these substances may be of concern given what is known about current human exposure levels. OHAT also organizes workshops or state-of-the-science evaluations to address issues of importance in environmental health sciences. Information about OHAT is found at http://ntp.niehs.nih.gov/go/ ohat. Background Information on NTP Peer Review Panels: NTP panels are technical, scientific advisory bodies established on an ‘‘as needed’’ basis to provide independent scientific peer review and advise the NTP on agents of public health concern, new/revised toxicological test methods, or other issues. These panels help ensure transparent, unbiased, and scientifically rigorous input to the program for its use in making credible decisions about human hazard, setting research and testing priorities, and providing information to regulatory agencies about alternative methods for toxicity screening. The NTP welcomes nominations of scientific experts for upcoming panels. Scientists interested in serving on an NTP panel should provide current curriculum vitae to the FOR FURTHER INFORMATION CONTACT. The authority for NTP panels is provided by 42 U.S.C. 217a; section 222 of the Public Health Service (PHS) Act, as amended. The panel is governed by the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: February 22, 2016. John R. Bucher, Associate Director, NTP. [FR Doc. 2016–04102 Filed 2–25–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request: The National Physician Survey of Precision Medicine in Cancer Treatment (NCI) Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute, the National Institutes of Health, has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on November 18, 2015 (80 FR 72077), and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information Contact: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call nontoll-free number 240–276–6806 or Email your request, including your address to: janet.demoor@nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925–NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists’ current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patientphysician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationallyrepresentative studies on this topic to date. There are only two non-federal studies two that have examined physicians’ knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to medical oncology physicians across the U.S. Nonrespondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 350. mstockstill on DSK4VPTVN1PROD with NOTICES TOTAL ANNUALIZED BURDEN HOURS Form name Type of respondent Telephone Screener ....................................... Precision Medicine Survey—Pilot Study ........ Precision Medicine Survey—Full Study .......... Non-response Follow-back Survey ................. Receptionists ...................... Oncology Physicians .......... Oncology Physicians .......... Oncology Physicians .......... VerDate Sep<11>2014 20:41 Feb 25, 2016 Jkt 238001 PO 00000 Frm 00066 Fmt 4703 Number of respondents Sfmt 4703 Number of responses per respondent 775 175 600 40 E:\FR\FM\26FEN1.SGM 1 1 1 1 26FEN1 Average burden per response (in hours) 3/60 20/60 20/60 5/60 Total annual burden hour 39 58 200 3 9870 Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices TOTAL ANNUALIZED BURDEN HOURS—Continued Average burden per response (in hours) Type of respondent Telephone Reminder Script ............................ Receptionists ...................... 600 1 5/60 50 Total ......................................................... ............................................. 1,375 2,190 ........................ 350 Dated: February 11, 2016. Karla Bailey, Project Clearance Liaison, National Cancer Institute, NIH. FOR FURTHER INFORMATION CONTACT: [FR Doc. 2016–04105 Filed 2–25–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0008] Agency Information Collection Activities: Application for Identification Card U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 30-Day notice and request for comments; Extension of an existing collection of information. AGENCY: U.S. Customs and Border Protection (CBP) of the Department of Homeland Security will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: Application for Identification Card (CBP Form 3078). This is a proposed extension of an information collection that was previously approved. CBP is proposing that this information collection be extended with no change to the burden hours or to the information collected. This document is published to obtain comments from the public and affected agencies. DATES: Written comments should be received on or before March 28, 2016 to be assured of consideration. ADDRESSES: Interested persons are invited to submit written comments on this proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the OMB Desk Officer for Customs and Border Protection, Department of Homeland Security, and sent via electronic mail to oira_submission@ omb.eop.gov or faxed to (202) 395–5806. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:41 Feb 25, 2016 Jkt 238001 Number of respondents Number of responses per respondent Form name Requests for additional information should be directed to Tracey Denning, U.S. Customs and Border Protection, Regulations and Rulings, Office of International Trade, 90 K Street NE., 10th Floor, Washington, DC 20229– 1177, at 202–325–0265. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register (80 FR 66915) on October 30, 2015, allowing for a 60-day comment period. This notice allows for an additional 30 days for public comments. This process is conducted in accordance with 5 CFR 1320.10. CBP invites the general public and other Federal agencies to comment on proposed and/ or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13; 44 U.S.C. 3507). The comments should address: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimates of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden, including the use of automated collection techniques or the use of other forms of information technology; and (e) the annual costs to respondents or record keepers from the collection of information (total capital/ startup costs and operations and maintenance costs). The comments that are submitted will be summarized and included in the CBP request for OMB approval. All comments will become a matter of public record. In this document, CBP is soliciting comments concerning the following information collection: Title: Application for Identification Card. OMB Number: 1651–0008. Form Number: CBP Form 3078. Abstract: CBP Form 3078, Application for Identification Card, is filled out in order to obtain an Identification Card which is used to gain access to CBP security areas. This form collects PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Total annual burden hour biographical information and is usually completed by licensed Cartmen or Lightermen whose duties require receiving, transporting, or otherwise handling imported merchandise which has not been released from CBP custody. This form is submitted to the local CBP office at the port of entry that the respondent will be requesting access to the Federal Inspection Section. Form 3078 is authorized by 19 U.S.C. 66, 1551, 1555, 1565, 1624, 1641; and 19 CFR 112.42, 118, 122.182, and 146.6. This form is accessible at: http://www. cbp.gov/sites/default/files/documents/ CBP%20Form%203078.pdf. Action: CBP proposes to extend the expiration date of this information collection with no change to the estimated burden hours or to CBP Form 3078. Type of Review: Extension (without change). Affected Public: Businesses. Estimated Number of Respondents: 150,000. Estimated Number of Total Annual Responses: 150,000. Estimated Time per Response: 17 minutes. Estimated Total Annual Burden Hours: 42,450. Dated: February 22, 2016. Tracey Denning, Agency Clearance Officer, U.S. Customs and Border Protection. [FR Doc. 2016–04121 Filed 2–25–16; 8:45 am] BILLING CODE 9111–14–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0014] Agency Information Collection Activities: Declaration for Free Entry of Unaccompanied Articles U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 60-Day notice and request for comments; extension of an existing collection of information. AGENCY: E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Notices]
[Pages 9869-9870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04105]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request: The National 
Physician Survey of Precision Medicine in Cancer Treatment (NCI)

    Summary: Under the provisions of Section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Cancer Institute, the 
National Institutes of Health, has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on November 
18, 2015 (80 FR 72077), and allowed 60-days for public comment. No 
public comments were received. The purpose of this notice is to allow 
an additional 30 days for public comment. The National Cancer Institute 
(NCI), National Institutes of Health, may not conduct or sponsor, and 
the respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30 days 
of the date of this publication.
    For Further Information Contact: To obtain a copy of the data 
collection plans and instruments, or request more information on the 
proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project 
Officer, Division of Cancer Control and Population Sciences, 9609 
Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call 
non-toll-free number 240-276-6806 or Email your request, including your 
address to: janet.demoor@nih.gov. Formal requests for additional plans 
and instruments must be requested in writing.
    Proposed Collection: The National Physician Survey of Precision 
Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), 
National Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of this study 
is to investigate the current practice of precision medicine in cancer 
treatment among medical oncologists in the U.S. This is a nationally 
representative survey designed to assess oncologists' current and 
potential use of genomic testing, to inform the development of 
interventions to facilitate optimal use of genomic testing and to 
improve patient-physician discussions of the risks, possible benefits, 
and uncertainties surrounding the use of these tests. Current knowledge 
of this topic is limited as there are no nationally-representative 
studies on this topic to date. There are only two non-federal studies 
two that have examined physicians' knowledge and attitudes regarding 
somatic genetic and genomic testing. The survey will be administered by 
mail and web to medical oncology physicians across the U.S. Non-
respondents will be invited to complete a follow-back survey to share 
their reasons for not participating. The study findings will inform NCI 
of relevant issues and concerns relating to the application of 
precision medicine to current and future cancer treatment patterns and 
practice. This information will also inform the development of new 
funding initiatives to optimize the use of precision medicine in cancer 
treatment. Additionally, information collected as part of this survey 
will be used to develop physician educational materials to address 
barriers to precision medicine in cancer care delivery.
    OMB approval is requested for 2 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 350.

                                          Total Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                     Type of         Number of       Number of      burden per     Total annual
           Form name               respondent       respondents    responses per   response  (in    burden hour
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Telephone Screener............  Receptionists...             775               1            3/60              39
Precision Medicine Survey--     Oncology                     175               1           20/60              58
 Pilot Study.                    Physicians.
Precision Medicine Survey--     Oncology                     600               1           20/60             200
 Full Study.                     Physicians.
Non-response Follow-back        Oncology                      40               1            5/60               3
 Survey.                         Physicians.

[[Page 9870]]

 
Telephone Reminder Script.....  Receptionists...             600               1            5/60              50
                                                 ---------------------------------------------------------------
    Total.....................  ................           1,375           2,190  ..............             350
----------------------------------------------------------------------------------------------------------------


    Dated: February 11, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2016-04105 Filed 2-25-16; 8:45 am]
 BILLING CODE 4140-01-P